Laura Girres, MD

Reims, Grand est

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 2678 - Safety of Concurrent Administration of TDM1 and Radiotherapy in Patients with HER2+ Breast Cancer with Residual Disease Post-Neoadjuvant Chemotherapy

  Monday, September 30, 2024
  3:00 PM – 4:00 PM ET